|   α7 nAchR-JAK2-STAT3 agonist 1 structure | Common Name | α7 nAchR-JAK2-STAT3 agonist 1 | ||
|---|---|---|---|---|
| CAS Number | 2108714-20-9 | Molecular Weight | 426.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H30O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of α7 nAchR-JAK2-STAT3 agonist 1α7 nAchR-JAK2-STAT3 agonist 1 is a potent α7 nAchR-JAK2-STAT3 agonist, with an IC50 value of 0.32 μM for nitric oxide (NO). α7 nAchR-JAK2-STAT3 agonist 1 effectively suppresses the expression of iNOS, IL-1β, and IL-6 in murine RAW264.7 macrophages. α7 nAchR-JAK2-STAT3 agonist 1 can inhibit LPS-induced NO release, NF-κB activation and cytokine production. α7 nAchR-JAK2-STAT3 can be used for researching sepsis[1]. | 
| Name | α7 nAchR-JAK2-STAT3 agonist 1 | 
|---|
| Description | α7 nAchR-JAK2-STAT3 agonist 1 is a potent α7 nAchR-JAK2-STAT3 agonist, with an IC50 value of 0.32 μM for nitric oxide (NO). α7 nAchR-JAK2-STAT3 agonist 1 effectively suppresses the expression of iNOS, IL-1β, and IL-6 in murine RAW264.7 macrophages. α7 nAchR-JAK2-STAT3 agonist 1 can inhibit LPS-induced NO release, NF-κB activation and cytokine production. α7 nAchR-JAK2-STAT3 can be used for researching sepsis[1]. | 
|---|---|
| Related Catalog | |
| Target | IC50: 0.32 μM (NO)[1] | 
| References | 
| Molecular Formula | C25H30O6 | 
|---|---|
| Molecular Weight | 426.50 |